In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

Cambridge, USA-based AI-driven biotech Insilico Medicine has announced a research collaboration with Eli Lilly, under which ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.

Duke researchers have developed a new AI-powered approach to nanoparticle drug delivery design, which performed well in lab tests with cancer drugs Drugs that fight diseases work best when they reach ...

The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...

At the 2025 World Internet Conference in Wuzhen, the global spotlight once again turned to this picturesque water town in southern China, as leaders from the internet and technology innovation sectors ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and ...

(Reuters) -U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical, deepening their use of artificial intelligence ...